Below you will find a list of potential funding opportunities for those looking to undertake COVID-19 research. This list will be updated with further information regularly.

Funding opportunities and guidance are evolving as the COVID-19 pandemic continues. If you can offer funding for research during the pandemic, or are aware of other organisations offering research funding that are not featured below, please get in touch and let us know.

COVID-19 Funding Dashboards

The following organisations are maintaining lists of funding opportunities for COVID-19 research:

  • GloPID-R Resources
    List of downloadable learning resources, funding opportunities, webinars and publications, all of which have been developed by GloPID-R members
  • Frontiers Cornonavirus Funding Monitor
    A curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research. Updated daily.
  • UKCDR - Funding Calls Dashboard
    The UK Collaborative on Development Research has developed a dashboard for the latest COVID-19 R&D funding opportunities. These range from major initiatives to small research grants, workshop and travel grants, prizes and awards, and individual fellowships and studentships. The dashboard collates funding opportunities for international development research based in the UK, but calls look to support international projects and work in LMICs.
  • RECOVR Funding Opportunities
    This page lists COVID-19-related funding opportunities, including both IPA-eligible and non-IPA-eligible opportunities

 

Specific COVID-19 Funding Sources

Organisation

Areas of Interest 

Further Information

National Science Foundation

The NSF is considering proposals for cooperative projects involving U.S. and foreign organizations.

  • To conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19.

  • To inform and educate about the science of virus transmission and prevention.

  • To encourage the development of processes and actions to address this global challenge.

Requests for the Rapid Response Research (RAPID) funding mechanism may be for up to $200K and up to one year in duration. Well-justified proposals that exceed these limits may be entertained. All questions should be directed either to a program officer managing an NSF program with which the research would be aligned or to: rapid-covid19@nsf.gov

Biomedical Advanced Research and Development Authority

BARDA is investing in an array of medical countermeasures to diagnose, treat, or protect against the 2019 novel coronavirus under the BARDA Broad Agency Announcement.

  • Diagnostic assays for human pan-coronaviruses

  • Point-of-Care diagnostic assays for SARS-CoV-2 virus

  • Diagnostic assay to detect COVID-19 disease

  • Nonclinical model

  • Vaccines for novel coronavirus

  • Therapeutics for novel coronavirus

  • Ventilators

  • Immunomodulators or therapeutics targeting lung repair

  • Pre-exposure and post-exposure prophylaxis for novel coronavirus exposure

  • Respiratory protective devices

  • Advanced Manufacturing Technologies

'If you are interested in partnering on a COVID-19 medical countermeasure, submit your ideas to a platform that reaches a host of potential federal partners! Submit a brief description and supporting materials through our CoronaWatch Portal.'

 

UKRI GCRF/Newton Fund Agile Response call to address COVID-19

Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the COVID-19 outbreak in countries identified on the OECD DAC list of ODA recipients.

 

 

UKRI will support excellent proposals which meet at least one of the following:

  • New research or innovation with a clear pathway to impact on policy or practice that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, response to, and recovery from the COVID-19 pandemic in a developing country context.
  • Supports the manufacture and/or wide scale adoption of an intervention with significant potential for impact in developing countries.
  • Gathers critical data and resources quickly for future research use.
 
  • Project length: up to 18 months
  • Eligibility: UK applicants must be eligible to receive Research Council funding.
    Additional eligibility rules apply for international applicants, please see below
  • Closing date: none – apply at any time
  • Funding: 80% of the full economic cost (fEC) for Research Council funding.
    Additional funding rules apply for international applicants, please see below
  • The primary benefit of proposals should be to any countries on the OECD DAC list of ODA recipients likely to be negatively impacted by COVID-19.
  • Award range: there is no specific budget for this call. We are interested in funding research of any scale that can demonstrate it will deliver impact during the lifetime of the project.

National Institute for Health Research

The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries.

 
The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation.
 
Applicants are required to ensure appropriate duty of care, insurance, safeguarding and all other liabilities are in place and that they have the support of their institution for any travel, as well as appropriate institutional support in the destination country.
 

Applications are open until further notice, on a rolling basis. Applications should ideally be submitted at least 2 weeks before the planned travel. 
 
Closes: 31 December 2020
 
Queries should be directed to ccf-nCoV@nihr.ac.uk.